Immunoassay determination of rapamycin: reliability of the method with respect to liquid chromatography mass spectrometric quantification
- 2 August 2007
- journal article
- research article
- Published by Wiley in Clinical Transplantation
- Vol. 21 (5), 633-637
- https://doi.org/10.1111/j.1399-0012.2007.00701.x
Abstract
Immunochemical assays represent a promising tool for quantification of immunosuppressants in organ transplanted patients, because they require small sample volumes and minimum sample pre-treatment; nevertheless considerations about method specificity, sensitivity and reproducibility cannot be overlooked. The present paper investigates the reliability of using the immunoparticle enzyme immunoassay (MEIA) for the quantification of blood rapamycin (RAPA) levels in therapeutic drug monitoring of renal transplanted patients with respect to a validated liquid chromatography tandem mass spectrometric (LC/ESI-MSMS) method, used as reference. Linearity of MEIA was tested over the range 0.0-30.0 ng/mL, with accuracy and precision within acceptable limits. Fifty-two blood samples were collected from 42 renal transplanted patients and analyzed simultaneously by both methods. The Pearson's regression analysis gave the following parameters: correlation equation [RAPA](MEIA) = 1.330 + 0.776 [RAPA](LC/ESI-MSMS), r = 0.8526, SD = 1.778, p < 0.0001. The obtained average rapamycin concentration was 8.8 +/- 3.4 ng/mL using MEIA and 9.6 +/- 3.7 ng/mL for LC/ESI-MSMS, with an overall underestimation of about 6% of the immunoenzymatic test. Accuracy of MEIA ranged from -33% to 36% with respect to the reference mass spectrometric method. Although immunoenzymatic test represents a fast and sufficiently accurate method for its use in clinical practice, specificity of the assay is still not sufficiently investigated and reference methods and/or Proficiency Testing Scheme should be used as external control.Keywords
This publication has 19 references indexed in Scilit:
- High-Performance Liquid Chromatography Versus Immunoassay for the Measurement of Sirolimus: Comparison of Two MethodsTransplantation Proceedings, 2006
- Determination of rapamycin: quantification of the sodiated species by an ion trap mass spectrometer as an alternative to the ammoniated complex analysis by triple quadrupoleRapid Communications in Mass Spectrometry, 2005
- Impact of gastric acid suppressants on cytochrome P450 3A4 and P-glycoprotein: Consequences for FK506 assimilationKidney International, 2005
- SIROLIMUS (RAPAMYCIN)-BASED THERAPY IN HUMAN RENAL TRANSPLANTATIONTransplantation, 1999
- IMMUNOSUPPRESSIVE EFFECTS AND SAFETY OF A SIROLIMUS/CYCLOSPORINE COMBINATION REGIMEN FOR RENAL TRANSPLANTATION1Transplantation, 1998
- HYPERLIPIDEMIA IN RENAL TRANSPLANT RECIPIENTS TREATED WITH SIROLIMUS(RAPAMYCIN)Transplantation, 1998
- Consensus Guidelines for Therapeutic Drug Monitoring of Rapamycin: Report of the Consensus PanelTherapeutic Drug Monitoring, 1995
- Sample clean-up and high-performance liquid chromatographic techniques for measurement of whole blood rapamycin concentrationsJournal of Chromatography B: Biomedical Sciences and Applications, 1994
- PROLONGATION OF CANINE PANCREATIC ISLET ALLOGRAFT SURVIVAL WITH COMBINED RAPAMYCIN AND CYCLOSPORINE THERAPY AT LOW DOSESTransplantation, 1993
- THE RELATIONSHIP OF BLOOD CONCENTRATIONS OF RAPAMYCIN AND CYCLOSPORINE TO SUPPRESSION OF ALLOGRAFT REJECTION IN A RABBIT HETEROTOPIC HEART TRANSPLANT MODEL1Transplantation, 1993